(Reuters) – The U.S. Food and Drug Administration declined to approve Verrica Pharmaceuticals Inc’s drug for the treatment of a viral skin disease known as molluscum contagiosum, the company said on Tuesday.
(Reporting by Bhanvi Satija, Amruta Khandekar and Sneha Bhowmik in Bengaluru; Editing by Subhranshu Sahu)
